LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 123

Search options

  1. Article ; Online: Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.

    Kroos, M A / Pomponio, R J / Hagemans, M L / Keulemans, J L M / Phipps, M / DeRiso, M / Palmer, R E / Ausems, M G E M / Van der Beek, N A M E / Van Diggelen, O P / Halley, D J J / Van der Ploeg, A T / Reuser, A J J

    Neurology

    2007  Volume 68, Issue 2, Page(s) 110–115

    Abstract: ... fatal symptom in the classic infantile subtype. c.-32-13T-->G is the most common mutation in adults ... G haplotypes in search for genotype-phenotype correlations.: Methods: We studied 98 compound ... heterozygotes with a fully deleterious mutation (11 novel mutations are described) and the common c.-32-13T-->G ...

    Abstract Background: Pompe disease (acid maltase deficiency, glycogen storage disease type II; OMIM 232300) is an autosomal recessive lysosomal storage disorder characterized by acid alpha-glucosidase deficiency due to mutations in the GAA gene. Progressive skeletal muscle weakness affects motor and respiratory functions and is typical for all forms of Pompe disease. Cardiac hypertrophy is an additional fatal symptom in the classic infantile subtype. c.-32-13T-->G is the most common mutation in adults.
    Objective: To delineate the disease variation among patients with this mutation and to define the c.-32-13T-->G haplotypes in search for genotype-phenotype correlations.
    Methods: We studied 98 compound heterozygotes with a fully deleterious mutation (11 novel mutations are described) and the common c.-32-13T-->G mutation.
    Results: All patients were Caucasian. None had the classic infantile form of Pompe disease. The clinical course varied far more than anticipated (age at diagnosis <1 to 78 years; age at onset: <1 to 52 years). The acid alpha-glucosidase activities in a subset of patients ranged from 4 to 19.9 nmol/mg/h. Twelve different c.-32-13T-->G haplotypes were identified based on 17 single-nucleotide polymorphisms located in the GAA gene. In 76% of the cases, c.-32-13T-->G was encountered in the second most common GAA core haplotype (DHRGEVVT). In only one case was c.-32-13T-->G encountered in the major GAA core haplotype (DRHGEIVT).
    Conclusion: Patients with the same c.-32-13T-->G haplotype (c.q. GAA genotype) may manifest first symptoms at different ages, indicating that secondary factors may substantially influence the clinical course of patients with this mutation.
    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cohort Studies ; DNA Mutational Analysis ; Female ; Genetic Predisposition to Disease/genetics ; Glycogen Storage Disease Type II/enzymology ; Glycogen Storage Disease Type II/epidemiology ; Glycogen Storage Disease Type II/genetics ; Haplotypes/genetics ; Humans ; Infant ; Infant, Newborn ; Internationality ; Male ; Middle Aged ; Mutation ; Prevalence ; Risk Assessment/methods ; alpha-Glucosidases/genetics
    Chemical Substances GAA protein, human (EC 3.2.1.20) ; alpha-Glucosidases (EC 3.2.1.20)
    Language English
    Publishing date 2007-01-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/01.wnl.0000252798.25690.76
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Protective Role of Self-Regulatory Efficacy: A Moderated Mediation Model on the Influence of Impulsivity on Cyberbullying through Moral Disengagement.

    Paciello, Marinella / Corbelli, Giuseppe / Di Pomponio, Ileana / Cerniglia, Luca

    Children (Basel, Switzerland)

    2023  Volume 10, Issue 2

    Abstract: During online interactions, adolescents are often exposed to deviant opportunities. In this context, the capacity to regulate one's behavior is essential to prevent cyberbullying. Among adolescents, this online aggressive behavior is a growing phenomenon, ...

    Abstract During online interactions, adolescents are often exposed to deviant opportunities. In this context, the capacity to regulate one's behavior is essential to prevent cyberbullying. Among adolescents, this online aggressive behavior is a growing phenomenon, and its deleterious effects on teenagers' mental health are well known. The present work argues the importance of self-regulatory capabilities under deviant peer pressure in preventing cyberbullying. In particular, focusing on two relevant risk factors, i.e., impulsivity and moral disengagement, we examine (1) the mediation role of moral disengagement in the process leading to cyberbullying from impulsivity; (2) the buffering effect of the perceived self-regulatory capability to resist deviant peer pressure in mitigating the effect of these impulsive and social-cognitive dimensions on cyberbullying. Moderated mediation analysis was performed on a sample of 856 adolescents; the results confirm that the perceived self-regulatory capability to resist peer pressure effectively mitigates the indirect effect of impulsivity through moral disengagement on cyberbullying. The practical implications of designing interventions to make adolescents more aware and self-regulated in their online social lives to counter cyberbullying are discussed.
    Language English
    Publishing date 2023-01-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2732685-8
    ISSN 2227-9067
    ISSN 2227-9067
    DOI 10.3390/children10020219
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Online: Il metodo clinico rivisitato

    Danieli, Giovanni / Pomponio, Giovanni

    Lezioni e seminari di clinica medica

    2006  

    Author's details edited by Giovanni Danieli, Giovanni Pomponio
    Keywords Internal medicine ; Medical Education
    Language Italian
    Publisher Springer
    Publishing place Milano
    Document type Book ; Online
    HBZ-ID TT050387932
    ISBN 978-88-470-0452-8 ; 978-88-470-0453-5 ; 88-470-0452-7 ; 88-470-0453-5
    DOI 10.1007/88-470-0453-5
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  4. Article ; Online: Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.

    Menditto, Vincenzo G / Moretti, Marco / Babini, Lucia / Mattioli, Annalisa / Giuliani, Andres Ramon / Fratini, Marina / Pallua, Fabienne Yvonne / Andreoli, Elisa / Nitti, Cinzia / Contucci, Susanna / Gabrielli, Armando / Rocchi, Marco Bruno Luigi / Pomponio, Giovanni

    Clinical chemistry and laboratory medicine

    2024  

    Abstract: Objectives: Data in literature indicate that in patients suffering a minor head injury (MHI), biomarkers serum levels could be effective to predict the absence of intracranial injury (ICI) on head CT scan. Use of these biomarkers in case of patients ... ...

    Abstract Objectives: Data in literature indicate that in patients suffering a minor head injury (MHI), biomarkers serum levels could be effective to predict the absence of intracranial injury (ICI) on head CT scan. Use of these biomarkers in case of patients taking oral anticoagulants who experience MHI is very limited. We investigated biomarkers as predictors of ICI in anticoagulated patients managed in an ED.
    Methods: We conducted a single-cohort, prospective, observational study in an ED. Our structured clinical pathway included a first head CT scan, 24 h observation and a second CT scan. The outcome was delayed ICI (dICI), defined as ICI on the second CT scan after a first negative CT scan. We assessed the sensitivity (SE), specificity (SP), negative predictive value (NNV) and positive predictive value (PPV) of the biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in order to identify dICI.
    Results: Our study population was of 234 patients with a negative first CT scan who underwent a second CT scan. The rate of dICI was 4.7 %. The NPV for the detection of dICI were respectively (IC 95 %): S100B 92.7 % (86.0-96.8 %,); ubiquitin C-terminal hydrolase-L1 (UCH-L1) 91.8 % (83.8-96.6 %); glial fibrillary protein (GFP) 100 % (83.2-100 %); TBI 100 % (66.4-100 %). The AUC for the detection of dICI was 0.407 for S100B, 0.563 for neuron-specific enolase (NSE), 0.510 for UCH-L1 and 0.720 for glial fibrillary acidic protein (GFAP), respectively.
    Conclusions: The NPV of the analyzed biomarkers were high and they potentially could limit the number of head CT scan for detecting dICI in anticoagulated patients suffering MHI. GFAP and Alinity TBI seem to be effective to rule out a dCI, but future trials are needed.
    Language English
    Publishing date 2024-01-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1418007-8
    ISSN 1437-4331 ; 1434-6621 ; 1437-8523
    ISSN (online) 1437-4331
    ISSN 1434-6621 ; 1437-8523
    DOI 10.1515/cclm-2023-1169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: University Teachers During the First Lockdown Due to SARS-CoV-2 in Italy: Stress, Issues and Perceptions of Misconduct.

    Parlangeli, Oronzo / Palmitesta, Paola / Bracci, Margherita / Marchigiani, Enrica / Di Pomponio, Ileana / Guidi, Stefano

    Science and engineering ethics

    2022  Volume 28, Issue 1, Page(s) 9

    Abstract: ... about the perceived occurrence, increase or decrease of misconduct in research (e.g., research misconduct ... by colleagues) and professional relationships (e.g., misbehaviors between colleagues, from students and ...

    Abstract With the spread of the pandemic and the introduction of measures aimed at its containment, it is necessary to understand in specific national contexts how home quarantine has affected the psychophysical well-being of academics, and their ability to maintain integrity. To this end we constructed an online questionnaire to investigate the levels of stress, well-being, and work-life balance in relationship with living and working conditions. Moreover, the questionnaire was designed to obtain information about the perceived occurrence, increase or decrease of misconduct in research (e.g., research misconduct by colleagues) and professional relationships (e.g., misbehaviors between colleagues, from students and toward students). The questionnaire was administered online by contacting faculty at three universities in Tuscany, Italy, asking them to relate their experience during the first lockdown (March-May 2020). Faculty members were invited to complete the questionnaire by their institutional e-mail account. The final sample consisted of 581 respondents. The results showed that inadequacies of the equipment, and particularly poor internet connection, were significantly correlated with main issues reported, such as relationships with students and research activities. Female teachers primarily suffered from stressful conditions, lacked well-being, and experienced work-life imbalance. Stress levels were related to perceptions of the frequency of misconduct and of an increase in their frequency during the period of home quarantine. Female professors, when compared to their male counterparts, perceived misconduct from students as increased and more frequent in the period of quarantine. Results point to a gender issue that is likely to arise from conditions of domestic activities imbalance and that increases stress and misconduct perception.
    MeSH term(s) COVID-19 ; Communicable Disease Control ; Female ; Humans ; Male ; Quarantine ; SARS-CoV-2 ; Universities
    Language English
    Publishing date 2022-02-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2136491-6
    ISSN 1471-5546 ; 1353-3452
    ISSN (online) 1471-5546
    ISSN 1353-3452
    DOI 10.1007/s11948-022-00362-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Minor head injury in anticoagulated patients: Outcomes and analysis of clinical predictors. A prospective study.

    Menditto, V G / Moretti, M / Babini, L / Sampaolesi, M / Buzzo, M / Montillo, L / Raponi, A / Riccomi, F / Marcosignori, M / Rocchi, M / Pomponio, G

    The American journal of emergency medicine

    2023  Volume 76, Page(s) 105–110

    Abstract: Background: The optimal management of patients taking oral anticoagulants who experience minor head injury (MHI) is unclear. The availability of validated protocols and reliable predictors of prognosis would be of great benefit. We investigated clinical ...

    Abstract Background: The optimal management of patients taking oral anticoagulants who experience minor head injury (MHI) is unclear. The availability of validated protocols and reliable predictors of prognosis would be of great benefit. We investigated clinical factors as predictors of clinical outcomes and intracranial injury (ICI).
    Methods: We conducted a single-cohort, prospective, observational study in an ED. Our structured clinical pathway included a first head CT scan, 24 h observation and a second CT scan. The primary outcome was the occurrence of MHI-related death or re-admission to ED at day +30. The secondary outcome was the rate of delayed ICI (dICI), defined as second positive CT scan after a first negative CT scan. We assessed some clinical predictors derived from guidelines and clinical prediction rules as potential risk factors for the outcomes.
    Results: 450 patients with a negative first CT scan who underwent a second CT scan composed our 'study population'. The rate of the primary outcome was 4%. The rate of the secondary outcome was 4.7%. Upon univariate and multivariate analysis no statistically significant predictors for the outcomes were found.
    Conclusions: Previous retrospective studies showed a lot of negative predictive factors for anticoagulated patients suffering a minor head injury. In our prospective study no clinical factors emerged as predictors of poor clinical outcomes and dICI. So, even if we confirmed a low rate of adverse outcomes, the best management of these patients in ED remains not so clear and future trials are needed.
    MeSH term(s) Humans ; Prospective Studies ; Craniocerebral Trauma/complications ; Craniocerebral Trauma/diagnostic imaging ; Anticoagulants/adverse effects ; Risk Factors ; Retrospective Studies
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2023-11-21
    Publishing country United States
    Document type Observational Study ; Journal Article
    ZDB-ID 605890-5
    ISSN 1532-8171 ; 0735-6757
    ISSN (online) 1532-8171
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2023.11.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Rituximab for eosinophilic granulomatosis with polyangiitis: a systematic review of observational studies.

    Menditto, Vincenzo G / Rossetti, Giulia / Olivari, Diletta / Angeletti, Alessia / Rocchi, Marco / Gabrielli, Armando / Pomponio, Giovanni

    Rheumatology (Oxford, England)

    2021  Volume 60, Issue 4, Page(s) 1640–1650

    Abstract: Objective: To analyse the available evidence about the use of rituximab (RTX) and other biologic agents in eosinophilic granulomatosis with polyangiitis (EGPA) patients and to provide useful findings to inform the design of future, reliable clinical ... ...

    Abstract Objective: To analyse the available evidence about the use of rituximab (RTX) and other biologic agents in eosinophilic granulomatosis with polyangiitis (EGPA) patients and to provide useful findings to inform the design of future, reliable clinical trials.
    Methods: A systematic review was performed. A systematic search was conducted in PubMed/MEDLINE, Scopus, Web of Science and the Cochrane library databases on RTX, and an extensive literature search was conducted on other biologic agents.
    Results: Forty-five papers pertinent to our questions were found: 16 retrospective cohort studies, 8 case series, 3 prospective cohort studies and 18 single case reports, for a total of 368 EGPA patients. More than 80% of evaluable patients achieved complete or partial remission with a tendency towards a higher rate of complete response in the pANCA-positive subgroup.
    Conclusion: Although the majority of the evaluable EGPA patients treated with RTX appears to achieve complete remission, we strongly believe that a number of sources of heterogeneity impair a clear interpretation of results and limit their transferability in clinical practice. Differences in design, enrolment criteria, outcome definition and measurement make a comparison among data obtained from studies on RTX and other biologic agents unreliable.
    MeSH term(s) Granulomatosis with Polyangiitis/drug therapy ; Humans ; Immunosuppressive Agents/therapeutic use ; Observational Studies as Topic ; Remission Induction ; Rituximab/therapeutic use ; Treatment Outcome
    Chemical Substances Immunosuppressive Agents ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2021-02-16
    Publishing country England
    Document type Journal Article ; Systematic Review
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keab046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book: Il destino di Arianna

    Pomponio, Giovanni

    manuale per l'uso critico delle linee guida

    (Metodi)

    2009  

    Author's details Giovanni Pomponio
    Series title Metodi
    MeSH term(s) Practice Guidelines as Topic ; Evaluation Studies as Topic
    Language Italian
    Size 184 p. :, ill.
    Edition 1. ed.
    Publisher SEEd
    Publishing place Torino
    Document type Book
    ISBN 9788889688434 ; 8889688432
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  9. Article ; Online: Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.

    Robbrecht, Debbie / Grob, Jean-Jacques / Bechter, Oliver / Simonelli, Matteo / Doger, Bernard / Borbath, Ivan / Butler, Marcus O / Cheng, Tina / Romano, Patricia Martin / Pons-Tostivint, Elvire / Di Nicola, Massimo / Curigliano, Giuseppe / Ryu, Min-Hee / Rodriguez-Vida, Alejo / Schadendorf, Dirk / Garralda, Elena / Abbadessa, Giovanni / Demers, Brigitte / Amrate, Amele /
    Wang, Hong / Lee, Joon Sang / Pomponio, Robert / Wang, Rui

    Clinical and translational science

    2024  Volume 17, Issue 2, Page(s) e13736

    Abstract: SAR439459, a 'second-generation' human anti-transforming growth factor-beta (TGFβ) monoclonal antibody, inhibits all TGFβ isoforms and improves the antitumor activity of anti-programmed cell death protein-1 therapeutics. This study reports the ... ...

    Abstract SAR439459, a 'second-generation' human anti-transforming growth factor-beta (TGFβ) monoclonal antibody, inhibits all TGFβ isoforms and improves the antitumor activity of anti-programmed cell death protein-1 therapeutics. This study reports the pharmacodynamics (PD) and biomarker results from phase I/Ib first-in-human study of SAR439459 ± cemiplimab in patients with advanced solid tumors (NCT03192345). In dose-escalation phase (Part 1), SAR439459 was administered intravenously at increasing doses either every 2 weeks (Q2W) or every 3 weeks (Q3W) with cemiplimab IV at 3 mg/kg Q2W or 350 mg Q3W, respectively, in patients with advanced solid tumors. In dose-expansion phase (Part 2), patients with melanoma received SAR439459 IV Q3W at preliminary recommended phase II dose (pRP2D) of 22.5/7.5 mg/kg or at 22.5 mg/kg with cemiplimab 350 mg IV Q3W. Tumor biopsy and peripheral blood samples were collected for exploratory biomarker analyses to assess target engagement and PD, and results were correlated with patients' clinical parameters. SAR439459 ± cemiplimab showed decreased plasma and tissue TGFβ, downregulation of TGFβ-pathway activation signature, modulation of peripheral natural killer (NK) and T cell expansion, proliferation, and increased secretion of CXCL10. Conversion of tumor tissue samples from 'immune-excluded' to 'immune-infiltrated' phenotype in a representative patient with melanoma SAR439459 22.5 mg/kg with cemiplimab was observed. In paired tumor and plasma, active and total TGFβ1 was more consistently elevated followed by TGFβ2, whereas TGFβ3 was only measurable (lower limit of quantitation ≥2.68 pg/mg) in tumors. SAR439459 ± cemiplimab showed expected peripheral PD effects and TGFβ alteration. However, further studies are needed to identify biomarkers of response.
    MeSH term(s) Humans ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Biomarkers ; Melanoma/drug therapy ; Transforming Growth Factor beta/antagonists & inhibitors ; Transforming Growth Factors/therapeutic use
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents ; Biomarkers ; cemiplimab (6QVL057INT) ; Transforming Growth Factor beta ; Transforming Growth Factors (76057-06-2)
    Language English
    Publishing date 2024-02-16
    Publishing country United States
    Document type Clinical Trial, Phase I ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2433157-0
    ISSN 1752-8062 ; 1752-8054
    ISSN (online) 1752-8062
    ISSN 1752-8054
    DOI 10.1111/cts.13736
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report.

    Pomponio, Giovanni / Olivari, Diletta / Mattioli, Massimo / Angeletti, Alessia / Rossetti, Giulia / Goteri, Gaia / Gabrielli, Armando

    Medicine

    2018  Volume 97, Issue 26, Page(s) e11143

    Abstract: Rationale: IgG4-related disease (IgG4-RD) is an emerging immune-mediated disease characterized by multi-organ involvement and variable clinical behavior.: Patient concerns: We describe the case of a 50-year-old woman affected by a rare variant of ... ...

    Abstract Rationale: IgG4-related disease (IgG4-RD) is an emerging immune-mediated disease characterized by multi-organ involvement and variable clinical behavior.
    Patient concerns: We describe the case of a 50-year-old woman affected by a rare variant of IgG4-RD, characterized by eyelid xanthelasmas, adult-onset asthma and salivary and lacrimal glands enlargement. Multiple lymphadenopathies and a pulmonary mass were present at initial evaluation.
    Inteventions: After a single course of rituximab (2g in 2 refracted doses), an almost complete clinical remission was achieved without chronic steroid administration.
    Outcomes: Magnetic resonance imaging (MRI), high-resolution computed tomography (HRCT) of the thorax, and positron emission tomography (18FDG-PET-CT) confirmed good response to treatment. Circulating plasmablasts dropped to undetectable levels as well. Xanthelasmas only remained unchanged. Remission persisted at 1-year follow-up.
    Lessons: Steroid therapy is still considered standard first-line therapy in IgG4-RD. However, high doses are generally required and relapses are common during the tapering phase. Rituximab is a well described steroid-sparing strategy, so far reserved to refractory cases only. In our experience, rituximab has been used as first-line monotherapy, showing great and sustained efficacy and optimal tolerability. The peculiar variant of IgG4-RD affecting our patient, the relatively low baseline plasmablast concentration, and the early placement of rituximab therapy may have facilitated the good response.
    MeSH term(s) Adult ; Asthma/complications ; Asthma/drug therapy ; Autoimmune Diseases/drug therapy ; Female ; Glucocorticoids/therapeutic use ; Humans ; Immunoglobulin G/blood ; Immunologic Factors/therapeutic use ; Magnetic Resonance Imaging ; Middle Aged ; Necrobiotic Xanthogranuloma/complications ; Necrobiotic Xanthogranuloma/drug therapy ; Plasma Cells ; Rituximab/therapeutic use ; Tomography, X-Ray Computed
    Chemical Substances Glucocorticoids ; Immunoglobulin G ; Immunologic Factors ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2018-06-25
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000011143
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top